Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues


The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.

No comments:

Post a Comment